Compounds > arginylphenylalaninamide
Page last updated: 2024-09-03

arginylphenylalaninamide and Prostatic Neoplasms

arginylphenylalaninamide has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeyaneethi, J; Karteris, E; Kawan, MA; Kyrou, I; Ramanjaneya, M; Randeva, HS; Williams, K1

Other Studies

1 other study(ies) available for arginylphenylalaninamide and Prostatic Neoplasms

ArticleYear
Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer.
    Oncology reports, 2019, Volume: 41, Issue:2

    Topics: Adiposity; Gene Expression; Humans; Male; Neuropeptides; PC-3 Cells; Prostatic Neoplasms; Receptors, G-Protein-Coupled

2019